Developer docs
API playgroundTry for free, no card

Search company profiles

Medical Innovation Xchange

Full company profile

uuid000kukg

Namestring
Medical Innovation Xchange
Legal namestring
Medical Innovation Xchange
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Medical Innovation Xchange (MIX) is a Kitchener, Ontario-based industry-led hub founded in 2019 to help Canadian medical technology startups scale. It operates two primary membership programs — a Residency Program for established companies and an Affiliate Program for earlier-stage ventures — anchored by the MIX Acceleration Zone, a co-located facility at 809 Wellington Street North that offers ISO 13485 and MDSAP certified manufacturing space, offices, and labs. As of the most recent reporting, the hub supports 22 member companies (6 Resident and 16+ Affiliate) spanning surgical robotics, diagnostics, digital health, women's health, and medical imaging.

MIX monetizes through subscription-style membership and program fees paid by its resident and affiliate companies; pricing is quote-based and not publicly disclosed. Beyond physical infrastructure, the hub delivers commercialization and go-to-market support, regulatory and quality-assurance navigation (including ISO 14971 training delivered in partnership with Intertek), IP advisory through partners such as ElevateIP and IPON, funding navigation via connections to FedDev Ontario, OBIO EAHN, TitletownTech, and the Ontario Life Sciences Innovation Fund, and a peer mentorship network led by experienced medtech operators such as Armen Bakirtzian (Intellijoint Surgical) and Abdallah El-Fallou (FluidAI). Member-company outcomes reported by MIX include $268M of capital raised, $177M of revenue generated, 300+ patents filed, 353,930 patients served, 336 new jobs in 2025, and 968 jobs maintained in 2025.

MIX is governed by an Executive Director (Elliot Fung) and a board that includes the founders and CEOs of member companies; it has no parent company, no disclosed external investors, and operates with a 1–10 person internal team. The organization is a private industry hub — not a technology vendor — and its competitive position rests on the density of its member ecosystem, the regulatory-grade infrastructure of the Acceleration Zone, and its integration with Ontario's broader medtech funding and clinical adoption channels.

Short descriptiontext

Medical Innovation Xchange (MIX) is a Kitchener, Ontario-based industry-led hub founded in 2019 that helps Canadian medical technology startups scale via Residency and Affiliate membership programs, ISO 13485/MDSAP certified manufacturing space, regulatory support, and a peer mentorship network of 22 medtech companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKitchener, Canada
HQ citystring
Kitchener
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medtech startup accelerator, medical device incubation, health innovation hub, regulatory compliance services, medtech commercialization support
Industry2 codes
1Quality Management & Regulatory Compliance (CLIA/CAP/ISO) for Labs
CodeHLACAMAHPrimaryYes
2Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration)
CodeHLACAPAJPrimaryNo
NAICS code2 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Commercial Physical & Biological Research8731
Product category
Medtech Startup Accelerator
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Membership and Program Fees
TypeSubscription Recurring
Description

MIX generates revenue through membership fees charged to Resident and Affiliate member companies in exchange for access to the MIX Acceleration Zone infrastructure, mentorship programming, regulatory/commercialization support, IP advisory, and the broader founder ecosystem.

medicalinnovationxchange.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Medical Innovation Xchange (MIX) operates an industry-led hub in Kitchener, Ontario that helps Canadian medical technology startups scale by providing co-located office, lab, and ISO 13485/MDSAP-certified manufacturing space, mentorship from successful medtech founders, regulatory and quality assurance navigation, IP advisory, and funding navigation. Its primary commercial offerings are the Residency Program (intensive, on-site support for more advanced companies) and the Affiliate Program (ecosystem access and peer mentorship for earlier-stage companies), underpinned by the MIX Acceleration Zone physical infrastructure and the MIX-Knowledge Xchange training/consulting program.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Medical Innovation Xchange (MIX) is Canada's first industry-led hub dedicated to helping medical technology startups scale successfully. MIX is not a single unified product but rather an ecosystem of programs and services. The core offerings include the Residency Program for intensive support of early-stage medtech companies, the Affiliate Program for peer collaboration and mentorship access, the MIX Acceleration Zone providing certified manufacturing and workspace facilities, and the MIX-Knowledge Xchange funding for training and consulting. MIX connects startups with world-class mentoring, commercialization support, regulatory navigation, operations assistance, and fundraising guidance to reduce barriers and bridge resource gaps facing medical technology startups.

Product and service4 records
1Residency Program
CategoryStartup Incubation Program
Description

Intensive support program providing world-class mentoring from successful medtech companies, commercialization and marketing strategies, business strategy support, regulatory and quality assurance navigation, operations support, and fundraising guidance for more advanced medical technology startups accepted into the hub.

2Affiliate Program
CategoryStartup Membership Program
Description

Membership program connecting earlier-stage medtech companies with MIX's ecosystem of mentors, founders, and industry leaders for peer collaboration, knowledge sharing, programming, and commercialization support without requiring full physical co-location in the Acceleration Zone.

3MIX Acceleration Zone
CategoryPhysical Infrastructure Facility
Description

Physical infrastructure at MIX headquarters providing co-located office, lab, and ISO 13485 and MDSAP certified manufacturing space for Resident member companies to conduct compliant medical device production within the hub.

4MIX-Knowledge Xchange
CategoryTraining and Consulting Program
Description

Funding program supporting knowledge translation, consulting, training, and upskilling initiatives for MIX member companies to accelerate their development and commercialization efforts.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-12
Description

MIX Executive Director Elliot Fung participated in the City of Kitchener's 2026 State of the City address, highlighting MIX as a pillar of Kitchener's health innovation ecosystem and showcasing member companies including Vena Medical.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-05
Description

Vivo Surgery, a MIX affiliate member, has a funded clinical deployment at Hamilton Health Sciences (HHS) through OBIO EAHN, deploying its surgical video intelligence platform in the neurosurgery department for remote access, digital teaching, and structured procedural review.

3Randa Mudathir (NovaSonix CEO)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-16
Description

NovaSonix Healthcare joined MIX, bringing its MSKNovaVue 3D ultrasound attachment technology and seeking peer mentorship on design-for-manufacture and quality/regulatory roadmap development from MIX member companies.

medicalinnovationxchange.com
Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-09-04
Description

MIX hosted ISO 14971:2019 Risk Management for Medical Devices training provided by Intertek, attended by resident and affiliate companies including Hyivy, FluidAI, Intellijoint, Vena Medical, Vessl, Tenomix, Cobionix, Revolve Surgical, and Exact Imaging.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-31
Description

Vivo Surgery received the inaugural HHS Drive Spark Award from Hamilton Health Sciences, recognizing its leadership in digital surgery, quality improvement, and global knowledge exchange.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

OBIO EAHN (Early-Adoption Health Innovation Program) provides funding and support to MIX member companies including Vivo Surgery for clinical deployment and adoption of health technologies within Ontario health systems.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

The Accelerator Centre in Waterloo Region refers early-stage companies to MIX and recommends MIX to founders reaching later stages, serving as a pipeline partner within the regional startup ecosystem.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Baylis Medical joined MIX as a Mentor Company, providing experienced medtech operational expertise to resident and affiliate member companies navigating commercialization and scaling challenges.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Founded by Hyivy Health CEO Rachel Bartholomew, Femtech Canada is a national network of 200+ women's health founders. MIX members including Hyivy and HerSay participate, and MIX supports the broader femtech ecosystem through programming and visibility.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

The University of Waterloo's Velocity Science incubator serves as a feeder program for MIX. Vena Medical and Cobionix originated from Velocity before joining MIX, and MIX leverages Waterloo's engineering talent pipeline.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Vena Medical participated in the Texas Medical Center HealthTech Accelerator (TMCx) before returning to Canada and joining MIX. The relationship reflects MIX's role as a landing pad for companies that have scaled internationally.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Canadian commercializer-accelerator dedicated to agri-tech, food, and broader life sciences with regional offices across Canada. Comparable medtech-adjacent mandate but different vertical focus; operates as a national network rather than a single Kitchener-anchored hub like MIX.

TypeDirect peer
Description

Toronto-based innovation hub supporting Ontario health and cleantech startups with curated programming, capital connections, and physical infrastructure. Both MIX and MaRS serve Canadian healthtech founders with a similar accelerator-plus-ecosystem model, though MaRS is significantly broader (multi-vertical) and larger.

TypeDirect peer
Description

Hospital-anchored accelerator in Los Angeles running cohort programs for medical device, digital health, and health AI startups with embedded clinical validation. Comparable to MIX's Residency/Affiliate Programs in combining infrastructure, mentorship, and clinical-deployment support for medtech founders.

TypeBroad incumbent
Description

Largest healthcare-dedicated, no-strings-attached incubator network operating JLABS sites across North America (Toronto, San Diego, Boston, etc.). Both JLABS and MIX provide physical lab/office infrastructure plus mentorship to early-stage life-sciences companies; MIX is essentially JLABS' Canada-equivalent in the medtech vertical but at a single-site, regional scale.

TypeDirect peer
Description

CDL operates venture-creation programs including a Health stream at UofT's Rotman School, focused on seed-to-Series A science-based startups. Both CDL and MIX run objective-driven cohort programs for Canadian science founders and compete for the same early-stage medtech pipeline in Ontario.

6Velocity (University of Waterloo)
TypeDirect peer
Description

UWaterloo's flagship on-campus incubator which MIX explicitly identifies as a feeder partner (Vena Medical and Cobionix originated there). Both support Canadian science-based startups, but Velocity is earlier-stage and broader (hardware/cleantech/software), whereas MIX is medtech-specialized and later-stage.

TypeDirect peer
Description

Brooklyn-based innovation hub offering physical prototyping infrastructure, venture-building services, and curated industry programs (including health). Both Newlab and MIX monetize through membership/site access and curate multi-company collaborations around shared technical facilities and ecosystem programming.

TypeDirect peer
Description

Houston TMC's accelerator for medical device and digital health startups, including the former TMCx program. MIX partner data explicitly references TMCx's relationship through Vena Medical; both provide curated cohort-based acceleration with clinical-validator access.

TypeDirect peer
Description

Provincial Ontario life-sciences trade and accelerator body that runs the EAHN program funding early-adoption health-tech deployments. MIX is a strategic EAHN partner and serves overlapping stakeholder communities, though OBIO is policy/grants-focused while MIX provides physical+programmatic infrastructure.

TypeDirect peer
Description

Global corporate-backed accelerator (with health-focused cohorts in Miami, Berlin, and Singapore) supporting digital health and medtech startups with mentorship, VC access, and corporate pilot pathways. Directly comparable cohort-based model to MIX's Residency Program, though operating across multiple geographies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers23 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medical Innovation Xchange

Medtech Startup Acceleratormedicalinnovationxchange.com

Medical Innovation Xchange (MIX) is a Kitchener, Ontario-based industry-led hub founded in 2019 that helps Canadian medical technology startups scale via Residency and Affiliate membership programs, ISO 13485/MDSAP certified manufacturing space, regulatory support, and a peer mentorship network of 22 medtech companies.

What Medical Innovation Xchange does

Medical Innovation Xchange (MIX) is a Kitchener, Ontario-based industry-led hub founded in 2019 to help Canadian medical technology startups scale. It operates two primary membership programs — a Residency Program for established companies and an Affiliate Program for earlier-stage ventures — anchored by the MIX Acceleration Zone, a co-located facility at 809 Wellington Street North that offers ISO 13485 and MDSAP certified manufacturing space, offices, and labs. As of the most recent reporting, the hub supports 22 member companies (6 Resident and 16+ Affiliate) spanning surgical robotics, diagnostics, digital health, women's health, and medical imaging.

MIX monetizes through subscription-style membership and program fees paid by its resident and affiliate companies; pricing is quote-based and not publicly disclosed. Beyond physical infrastructure, the hub delivers commercialization and go-to-market support, regulatory and quality-assurance navigation (including ISO 14971 training delivered in partnership with Intertek), IP advisory through partners such as ElevateIP and IPON, funding navigation via connections to FedDev Ontario, OBIO EAHN, TitletownTech, and the Ontario Life Sciences Innovation Fund, and a peer mentorship network led by experienced medtech operators such as Armen Bakirtzian (Intellijoint Surgical) and Abdallah El-Fallou (FluidAI). Member-company outcomes reported by MIX include $268M of capital raised, $177M of revenue generated, 300+ patents filed, 353,930 patients served, 336 new jobs in 2025, and 968 jobs maintained in 2025.

MIX is governed by an Executive Director (Elliot Fung) and a board that includes the founders and CEOs of member companies; it has no parent company, no disclosed external investors, and operates with a 1–10 person internal team. The organization is a private industry hub — not a technology vendor — and its competitive position rests on the density of its member ecosystem, the regulatory-grade infrastructure of the Acceleration Zone, and its integration with Ontario's broader medtech funding and clinical adoption channels.

Medical Innovation Xchange firmographics

Firmographics
Name
Medical Innovation Xchange
Legal name
Medical Innovation Xchange
Website
https://medicalinnovationxchange.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Medical Innovation Xchange (MIX) is a Kitchener, Ontario-based industry-led hub founded in 2019 that helps Canadian medical technology startups scale via Residency and Affiliate membership programs, ISO 13485/MDSAP certified manufacturing space, regulatory support, and a peer mentorship network of 22 medtech companies.
Ownership category
akta.pro rank

Medical Innovation Xchange industry classification

Industry
Product category
Medtech Startup Accelerator
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Quality Management & Regulatory Compliance (CLIA/CAP/ISO) for Labs (HLACAMAH)
akta.pro secondary industry
Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration) (HLACAPAJ)

Keywords

  • Medtech startup accelerator
  • Medical device incubation
  • Health innovation hub
  • Regulatory compliance services
  • Medtech commercialization support

Where Medical Innovation Xchange is headquartered

Location

Headquarters

HQ city
Kitchener
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Medical Innovation Xchange business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Membership and Program Fees: MIX generates revenue through membership fees charged to Resident and Affiliate member companies in exchange for access to the MIX Acceleration Zone infrastructure, mentorship programming, regulatory/commercialization support, IP advisory, and the broader founder ecosystem.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Medical Innovation Xchange product offering

Product offering

Core offering

Medical Innovation Xchange (MIX) operates an industry-led hub in Kitchener, Ontario that helps Canadian medical technology startups scale by providing co-located office, lab, and ISO 13485/MDSAP-certified manufacturing space, mentorship from successful medtech founders, regulatory and quality assurance navigation, IP advisory, and funding navigation. Its primary commercial offerings are the Residency Program (intensive, on-site support for more advanced companies) and the Affiliate Program (ecosystem access and peer mentorship for earlier-stage companies), underpinned by the MIX Acceleration Zone physical infrastructure and the MIX-Knowledge Xchange training/consulting program.

Product overview

Medical Innovation Xchange (MIX) is Canada's first industry-led hub dedicated to helping medical technology startups scale successfully. MIX is not a single unified product but rather an ecosystem of programs and services. The core offerings include the Residency Program for intensive support of early-stage medtech companies, the Affiliate Program for peer collaboration and mentorship access, the MIX Acceleration Zone providing certified manufacturing and workspace facilities, and the MIX-Knowledge Xchange funding for training and consulting. MIX connects startups with world-class mentoring, commercialization support, regulatory navigation, operations assistance, and fundraising guidance to reduce barriers and bridge resource gaps facing medical technology startups.

Differentiator

Problem solved

Functional benefit

Products and services

  • Residency Program Intensive support program providing world-class mentoring from successful medtech companies, commercialization and marketing strategies, business strategy support, regulatory and quality assurance navigation, operations support, and fundraising guidance for more advanced medical technology startups accepted into the hub.
  • Affiliate Program Membership program connecting earlier-stage medtech companies with MIX's ecosystem of mentors, founders, and industry leaders for peer collaboration, knowledge sharing, programming, and commercialization support without requiring full physical co-location in the Acceleration Zone.
  • MIX Acceleration Zone Physical infrastructure at MIX headquarters providing co-located office, lab, and ISO 13485 and MDSAP certified manufacturing space for Resident member companies to conduct compliant medical device production within the hub.
  • MIX-Knowledge Xchange Funding program supporting knowledge translation, consulting, training, and upskilling initiatives for MIX member companies to accelerate their development and commercialization efforts.

Companies that use Medical Innovation Xchange

Customer profile

Named customers23 records

Segments1 record

Ideal customer profiles1 record

Medical Innovation Xchange technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Medical Innovation Xchange partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • City of KitchenercoreStrategic or Co-development Partner · 12 June 2026MIX Executive Director Elliot Fung participated in the City of Kitchener's 2026 State of the City address, highlighting MIX as a pillar of Kitchener's health innovation ecosystem and showcasing member companies including Vena Medical.
  • Hamilton Health SciencescoreStrategic or Co-development Partner · 5 June 2026Vivo Surgery, a MIX affiliate member, has a funded clinical deployment at Hamilton Health Sciences (HHS) through OBIO EAHN, deploying its surgical video intelligence platform in the neurosurgery department for remote access, digital teaching, and structured procedural review.
  • Randa Mudathir (NovaSonix CEO)minorStrategic or Co-development Partner · 16 January 2026NovaSonix Healthcare joined MIX, bringing its MSKNovaVue 3D ultrasound attachment technology and seeking peer mentorship on design-for-manufacture and quality/regulatory roadmap development from MIX member companies.
  • IntertekminorImplementation/ SI/ Consulting Partner · 4 September 2025MIX hosted ISO 14971:2019 Risk Management for Medical Devices training provided by Intertek, attended by resident and affiliate companies including Hyivy, FluidAI, Intellijoint, Vena Medical, Vessl, Tenomix, Cobionix, Revolve Surgical, and Exact Imaging.
  • Hamilton Health SciencescoreStrategic or Co-development Partner · 31 July 2025Vivo Surgery received the inaugural HHS Drive Spark Award from Hamilton Health Sciences, recognizing its leadership in digital surgery, quality improvement, and global knowledge exchange.
  • Ontario Bioscience Innovation Organization (OBIO)coreStrategic or Co-development PartnerOBIO EAHN (Early-Adoption Health Innovation Program) provides funding and support to MIX member companies including Vivo Surgery for clinical deployment and adoption of health technologies within Ontario health systems.
  • Accelerator CentreminorChannel Partner/ Reseller/ DistributorThe Accelerator Centre in Waterloo Region refers early-stage companies to MIX and recommends MIX to founders reaching later stages, serving as a pipeline partner within the regional startup ecosystem.
  • Baylis Medical (as MIX Mentor Company)minorStrategic or Co-development PartnerBaylis Medical joined MIX as a Mentor Company, providing experienced medtech operational expertise to resident and affiliate member companies navigating commercialization and scaling challenges.
  • Femtech CanadaminorStrategic or Co-development PartnerFounded by Hyivy Health CEO Rachel Bartholomew, Femtech Canada is a national network of 200+ women's health founders. MIX members including Hyivy and HerSay participate, and MIX supports the broader femtech ecosystem through programming and visibility.
  • University of Waterloo (Velocity Science)minorStrategic or Co-development PartnerThe University of Waterloo's Velocity Science incubator serves as a feeder program for MIX. Vena Medical and Cobionix originated from Velocity before joining MIX, and MIX leverages Waterloo's engineering talent pipeline.
  • Texas Medical Center HealthTech Accelerator (formerly TMCx)minorStrategic or Co-development PartnerVena Medical participated in the Texas Medical Center HealthTech Accelerator (TMCx) before returning to Canada and joining MIX. The relationship reflects MIX's role as a landing pad for companies that have scaled internationally.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Medical Innovation Xchange competitors and assessment

Company assessment

Regional players

  • BioEnterprise: Canadian commercializer-accelerator dedicated to agri-tech, food, and broader life sciences with regional offices across Canada. Comparable medtech-adjacent mandate but different vertical focus; operates as a national network rather than a single Kitchener-anchored hub like MIX.

Direct peers

  • MaRS Discovery District: Toronto-based innovation hub supporting Ontario health and cleantech startups with curated programming, capital connections, and physical infrastructure. Both MIX and MaRS serve Canadian healthtech founders with a similar accelerator-plus-ecosystem model, though MaRS is significantly broader (multi-vertical) and larger.
  • Cedars-Sinai Accelerator: Hospital-anchored accelerator in Los Angeles running cohort programs for medical device, digital health, and health AI startups with embedded clinical validation. Comparable to MIX's Residency/Affiliate Programs in combining infrastructure, mentorship, and clinical-deployment support for medtech founders.
  • Creative Destruction Lab (CDL): CDL operates venture-creation programs including a Health stream at UofT's Rotman School, focused on seed-to-Series A science-based startups. Both CDL and MIX run objective-driven cohort programs for Canadian science founders and compete for the same early-stage medtech pipeline in Ontario.
  • Velocity (University of Waterloo): UWaterloo's flagship on-campus incubator which MIX explicitly identifies as a feeder partner (Vena Medical and Cobionix originated there). Both support Canadian science-based startups, but Velocity is earlier-stage and broader (hardware/cleantech/software), whereas MIX is medtech-specialized and later-stage.
  • Newlab: Brooklyn-based innovation hub offering physical prototyping infrastructure, venture-building services, and curated industry programs (including health). Both Newlab and MIX monetize through membership/site access and curate multi-company collaborations around shared technical facilities and ecosystem programming.
  • Texas Medical Center Innovation (TMCi): Houston TMC's accelerator for medical device and digital health startups, including the former TMCx program. MIX partner data explicitly references TMCx's relationship through Vena Medical; both provide curated cohort-based acceleration with clinical-validator access.
  • Ontario Bioscience Innovation Organization (OBIO): Provincial Ontario life-sciences trade and accelerator body that runs the EAHN program funding early-adoption health-tech deployments. MIX is a strategic EAHN partner and serves overlapping stakeholder communities, though OBIO is policy/grants-focused while MIX provides physical+programmatic infrastructure.
  • Startupbootcamp Digital Health: Global corporate-backed accelerator (with health-focused cohorts in Miami, Berlin, and Singapore) supporting digital health and medtech startups with mentorship, VC access, and corporate pilot pathways. Directly comparable cohort-based model to MIX's Residency Program, though operating across multiple geographies.

Broad incumbents

  • Johnson & Johnson Innovation - JLABS: Largest healthcare-dedicated, no-strings-attached incubator network operating JLABS sites across North America (Toronto, San Diego, Boston, etc.). Both JLABS and MIX provide physical lab/office infrastructure plus mentorship to early-stage life-sciences companies; MIX is essentially JLABS' Canada-equivalent in the medtech vertical but at a single-site, regional scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Medical Innovation Xchange financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medical Innovation Xchange leadership team

Management profile

Number of profiles

Profiles5 records

Medical Innovation Xchange funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medical Innovation Xchange M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Innovation Xchange

What does Medical Innovation Xchange do?

Medical Innovation Xchange (MIX) operates an industry-led hub in Kitchener, Ontario that helps Canadian medical technology startups scale by providing co-located office, lab, and ISO 13485/MDSAP-certified manufacturing space, mentorship from successful medtech founders, regulatory and quality assurance navigation, IP advisory, and funding navigation. Its primary commercial offerings are the Residency Program (intensive, on-site support for more advanced companies) and the Affiliate Program (ecosystem access and peer mentorship for earlier-stage companies), underpinned by the MIX Acceleration Zone physical infrastructure and the MIX-Knowledge Xchange training/consulting program.

Is Medical Innovation Xchange a public or private company?

Medical Innovation Xchange is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Medical Innovation Xchange founded?

Medical Innovation Xchange was founded in 2019. It employs 1 to 10 people.

Where is Medical Innovation Xchange based?

Medical Innovation Xchange is headquartered in Kitchener, Canada, in the North America region.

How does Medical Innovation Xchange make money?

One revenue line is on record: membership and Program Fees.

Who are Medical Innovation Xchange's main competitors?

BioEnterprise is listed as a regional player. Direct peers are MaRS Discovery District, Cedars-Sinai Accelerator, Creative Destruction Lab (CDL), Velocity (University of Waterloo), Newlab, Texas Medical Center Innovation (TMCi), Ontario Bioscience Innovation Organization (OBIO) and Startupbootcamp Digital Health. Johnson & Johnson Innovation - JLABS is listed as a broad incumbent.

Does Medical Innovation Xchange have an API?

No public API is recorded for Medical Innovation Xchange.

What industry is Medical Innovation Xchange in?

Medical Innovation Xchange's product category is Medtech Startup Accelerator. Its primary akta.pro industry code is HLACAMAH, Quality Management & Regulatory Compliance (CLIA/CAP/ISO) for Labs, with a secondary code of HLACAPAJ, Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration). Its NAICS code is 3345 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TipranksMedical Innovation Xchange Expands MedTech Ecosystem Reach Through Western MedTech CollaborationMedical Innovation Xchange expanded its MedTech ecosystem through a virtual collaboration session with Western MedTech, involving Canadian MedTech and HealthTech startups, including Cobionix Corporation, Vessl Prosthetics, and AiimSense Inc. The event aims to enhance deal flow, network effects, and ecosystem influence, with a focus on future growth opportunities for member companies.GlobeNewswireProvince supports MedTech Centre of Excellence at Medical Innovation Xchange (MIX)Ontario's Ministry of Labour, Training and Skills Development announced a $1.6M investment to support the Medical Innovation Xchange (MIX) MedTech Centre of Excellence. The funds will train and upskill up to 400 people and purchase advanced equipment, with applications expected later this year.GlobeNewswireMedical Innovation Xchange Appoints Elliot Fung As Executive DirectorMedical Innovation Xchange appointed Elliot Fung as its inaugural Executive Director, tasked with building Canada's domestic medical technology ecosystem. Fung previously served as Vice President of Innovation & Strategic Partnerships at Ontario Health and has held senior public affairs roles. MIX, founded in 2019, aims to help Canadian MedTech companies achieve global scale.GlobeNewswireMedical Innovation Xchange Collaborates with Province of Ontario to Help Fight COVID-19Medical Innovation Xchange announced a collaboration with the Ontario government to offer free advisory services to Ontario Together Fund recipients and companies with provincial purchase orders. The advisory aims to help increase efficiency, navigate regulatory challenges, and accelerate delivery of medical supplies. The initiative follows the province's stage 1 reopening and potential vaccine promise.GlobeNewswireCanada’s first industry-led medtech startup incubator accepting applications for Resident Program beginning Spring 2020Medical Innovation Xchange (MIX), Canada's first industry-led medtech incubator, is accepting applications for its 2020 Residency program starting this spring. The program, spearheaded by Intellijoint Surgical, offers residents mentorship and resources to avoid early-stage pitfalls. MIX does not take equity in participating companies.GlobeNewswireMedtech CEO Armen Bakirtzian paying it forward by creating incubator to keep IP in Canada & foster Canadian talentMedical Innovation Xchange (MIX), Canada's first industry-led medtech incubator, launched on January 10, 2020 in Kitchener, spearheaded by Intellijoint Surgical CEO Armen Bakirtzian. MIX is a non-profit that does not take equity, aiming to help Canadian medtech startups retain ownership and avoid moving operations to the U.S. Applications for the Spring 2020 residency are now open.